Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Akari Therapeutics ( (AKTX) ) just unveiled an update.
Akari Therapeutics announced a leadership change, with the termination of Wendy DiCicco’s role as Interim Chief Financial Officer. Samir Patel, the Interim CEO, has been appointed as Interim Principal Financial Officer and Principal Accounting Officer while the search for a permanent CFO is underway.
More about Akari Therapeutics
YTD Price Performance: -68.59%
Average Trading Volume: 37,647
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $11.9M
See more data about AKTX stock on TipRanks’ Stock Analysis page.
